Juan Guzman Galvan

List of publications:

BibTeX-Download

Urologische Klinik

Publications

(8)

NanoLuc Binary Technology as a methodological approach: an important new tool for studying the localization of androgen receptor and androgen receptor splice variant V7 homo and heterodimers (2024) Guzman J, Weigelt K, Neumann AD, Tripal P, Schmid B, Winter Z, Palmisano R, et al. Journal article Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer Patients (2022) Lieb V, Abdulrahman A, Weigelt K, Hauch S, Gombert M, Guzman J, Bellut L, et al. Journal article Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients (2022) Fichte A, Neumann AD, Weigelt K, Guzman J, Jansen T, Keinert J, Serrero G, et al. Journal article Cell-free dna variant sequencing using plasma and ar-v7 testing of circulating tumor cells in prostate cancer patients (2021) Lieb V, Bellut L, Abdulrahman A, Weigelt K, Hauch S, Gombert M, Guzman J, et al. Journal article Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma (2020) Kunz M, Brandl M, Bhattacharya A, Nobereit-Siegel L, Ewe A, Weirauch U, Hering D, et al. Journal article Expression of AR-V7 (Androgen receptor variant 7) protein in granular cytoplasmic structures is an independent prognostic factor in prostate cancer patients (2020) König P, Eckstein M, Jung R, Abdulrahman A, Guzman J, Weigelt K, Serrero G, et al. Journal article Progranulin (GP88) is an independent prognostic factor for prostate cancer patients (2020) Taubert H, Abdulrahman A, Eckstein M, Jung R, Guzman J, Weigelt K, Serrero G, et al. Conference contribution Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients (2019) Abdulrahman A, Eckstein M, Jung R, Guzman J, Weigelt K, Serrero G, Yue B, et al. Journal article